FDA Expands Darzalex Faspro Indication in Myeloma

The combination was approved for induction and consolidation in transplant-eligible patients with newly diagnosed multiple myeloma.
Medscape Medical News

source https://www.medscape.com/viewarticle/fda-expands-darzalex-faspro-indication-myeloma-2024a1000e30?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension

RA and RA-ILD Linked to Higher Lung Cancer Risk

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?